Immediate Impact

4 from Science/Nature 70 standout
Sub-graph 1 of 22

Citing Papers

Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy
2024 Standout
Metabolic reprogramming in cancer: Mechanisms and therapeutics
2023 Standout
2 intermediate papers

Works of Takuya Fujishima being referenced

Serum Surfactant Proteins A and D as Prognostic Factors in Idiopathic Pulmonary Fibrosis and Their Relationship to Disease Extent
2000
Aberrant Appearance of Lung Surfactant Protein A in Sera of Patients with Idiopathic Pulmonary Fibrosis and Its Clinical Significance
1995

Author Peers

Author Last Decade Papers Cites
Takuya Fujishima 379 63 8 89 22 446
Konstantinos Kagouridis 425 51 3 113 18 464
I Richmond 215 90 15 157 23 510
Toshihide Hayano 211 37 28 52 20 450
Nobuyuki Katayama 278 30 19 124 32 384
June Hyuk Lee 203 62 5 179 17 380
Theodore Ehrenreich 122 75 10 42 31 496
Juan Escrivá 301 69 14 51 25 430
Sanjita Ravishankar 95 78 10 45 18 486
Nathan Hatton 267 59 9 52 27 471
Moonja Chung‐Park 122 80 6 40 17 387

All Works

Loading papers...

Rankless by CCL
2026